Asosiy kontentga oʻtish
AkademIndex

Xizmatlar

← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

27 ta ish

Ish: Patient and health-care worker perspectives on the short-course regimen for treatment of drug-resistant tuberculosis in Karakalpakstan, Uzbekistan

  1. Short, Highly Effective, and Inexpensive Standardized Treatment of Multidrug-resistant Tuberculosis

    Armand Van Deun, Aung Kya Jai Maug, Md Abdul Hamid Salim +4

    MaqolaOchiq kirish201012 iqtibos
    ABI

  2. Global tuberculosis report (2014)

    L.A. Gabbasova, E.R. Experts Who

    Maqola20148 iqtibos
    ABI

  3. A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis

    Andrew Nunn, Patrick Phillips, Sarah Meredith +16

    MaqolaOchiq kirish20196 iqtibos
    ABI

  4. High cure rate with standardised short-course multidrug-resistant tuberculosis treatment in Niger: no relapses

    Alberto Piubello, Souleymane Hassane Harouna, Mahamadou Bassirou Souleymane +5

    Maqola20146 iqtibos
    ABI

  5. The Discovery of Grounded Theory; Strategies for Qualitative Research

    Barney G. Glaser, Anselm L. Strauss, Elizabeth Strutzel

    Maqola19686 iqtibos
    ABI

  6. High effectiveness of a 12-month regimen for MDR-TB patients in Cameroon

    Christopher Kuaban, J Noeske, Hans L. Rieder +3

    MaqolaOchiq kirish20155 iqtibos
    ABI

  7. Regimens to treat multidrug-resistant tuberculosis: past, present and future perspectives

    Emanuele Pontali, Mario Raviǵlione, Giovanni Battista Migliori

    Sharh maqolaOchiq kirish20195 iqtibos
    ABI

  8. Where there is hope: a qualitative study examining patients’ adherence to multi-drug resistant tuberculosis treatment in Karakalpakstan, Uzbekistan

    Shona Horter, Beverley Stringer, Jane Greig +5

    MaqolaOchiq kirishTuberculosis Research and EpidemiologyBMC Infectious Diseases20164 iqtibos
    ABI

  9. Effectiveness and safety of standardised shorter regimens for multidrug-resistant tuberculosis: individual patient data and aggregate data meta-analyses

    Faiz Ahmad Khan, M Salim, Philipp du Cros +9

    Sharh maqolaOchiq kirishTuberculosis Research and EpidemiologyEuropean Respiratory Journal20174 iqtibos
    ABI

  10. Principles for designing future regimens for multidrug-resistant tuberculosis

    Grania Brigden, Bern-Thomas Nyang’wa, Philipp du Cros +9

    MaqolaOchiq kirish20133 iqtibos
    ABI

  11. Impact of patient and program factors on default during treatment of multidrug-resistant tuberculosis

    Ma Tarcela Gler, Laura Jean Podewils, N. Munez +3

    MaqolaOchiq kirish20123 iqtibos
    ABI

  12. “When Treatment Is More Challenging than the Disease”: A Qualitative Study of MDR-TB Patient Retention

    Kalpita Shringarpure, Petros Isaakidis, Karuna D. Sagili +3

    Maqola20163 iqtibos
    ABI

  13. The Discovery of Grounded Theory: Strategies for Qualitative Research.

    Helmut R. Wagner, Barney G. Glaser, Anselm L. Strauss

    Maqola19683 iqtibos
    ABI

  14. ‘They prefer hidden treatment': anti-tuberculosis drug-taking practices and drug regulation in Karakalpakstan

    Beverley Stringer, Karen Lowton, Mirzagaleb N. Tillashaikhov +5

    MaqolaOchiq kirishTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease20162 iqtibos
    ABI

  15. Recent controversies about <scp>MDR</scp> and <scp>XDR‐TB</scp>: <scp>G</scp>lobal implementation of the <scp>WHO</scp> shorter <scp>MDR‐TB</scp> regimen and bedaquiline for all with <scp>MDR‐TB</scp>?

    Keertan Dheda, Helen Cox, Aliasgar Esmail +3

    Sharh maqolaOchiq kirish20172 iqtibos
    ABI

  16. Sampling for qualitative research

    Martin Marshall

    Maqola19962 iqtibos
    ABI

  17. Rethinking the patient: using Burden of Treatment Theory to understand the changing dynamics of illness

    Carl May, David T. Eton, Kasey R. Boehmer +9

    MaqolaOchiq kirish20142 iqtibos
    ABI

  18. Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies

    Simon Tiberi, Nelita du Plessis, Gerhard Walzl +11

    Sharh maqola20182 iqtibos
    ABI

  19. New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis

    Denise Rossato Silva, Margareth Pretti Dalcolmo, Simon Tiberi +9

    Sharh maqola20182 iqtibos
    ABI

  20. Applicability of the shorter ‘Bangladesh regimen’ in high multidrug-resistant tuberculosis settings

    Giovanni Sotgiu, Simon Tiberi, Rosella Centis +4

    Maqola20162 iqtibos
    ABI

  21. Limited Benefit of the New Shorter Multidrug-Resistant Tuberculosis Regimen in Europe

    Christoph Lange, Raquel Duarte, M. Jachym +7

    Boshqa20162 iqtibos
    ABI

  22. Psycho-Socio-Economic Issues Challenging Multidrug Resistant Tuberculosis Patients: A Systematic Review

    Beena Thomas, Poonguzhali Shanmugam, Malaisamy Muniyandi +5

    Sharh maqola20162 iqtibos
    ABI

  23. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  24. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  25. Sarlavhasiz

    Boshqa1 iqtibos
    ABI